S&P 500 Futures
(0.12%) 5 333.75 points

Dow Jones Futures
(0.08%) 40 168 points

Nasdaq Futures
(0.18%) 18 670 points

Oil
(0.27%) $80.28

Gas
(1.83%) $2.67

Gold
(0.82%) $2 437.20

Silver
(1.97%) $31.88

Platinum
(-0.61%) $1 083.30

USD/EUR
(-0.10%) $0.919

USD/NOK
(-0.03%) $10.67

USD/GBP
(-0.01%) $0.787

USD/RUB
(0.07%) $91.03

Realtime updates for CrystalGenomics, Inc. [083790.KQ]

Exchange: KOSDAQ

Last Updated20 May 2024 @ 02:19

25% discount on Stockinvest.us - Use code: Podcast

-1.15% KRW 2 590.00

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 02:19):

CrystalGenomics, Inc., a biopharmaceutical company, discovers and develops structural chemoproteiomics-based drugs in Korea. Its lead development candidate is NSAID (CG100649), which is a tissue specific anti-inflammatory agent with cardiovascular, gastrointestinal, and renal safety profiles that has completed Phase IIa clinical trial...

Stats
Today's Volume	329 647
Average Volume	373 289
Market Cap	198.29B
EPS	KRW0 ( 2024-05-16 )
Next earnings date	( KRW0 ) 2024-08-15
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW9.21 (0.36%)

Volume Correlation

Long: -0.15 (neutral)

Short: -0.05 (neutral)

Signal:(67.986) Neutral

CrystalGenomics, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CrystalGenomics, Inc. Correlation - Currency/Commodity

0.29
( neutral )

0.40
( neutral )

-0.07
( neutral )

0.34
( neutral )

0.68
( moderate )

-0.34
( neutral )

CrystalGenomics, Inc. Financials

Annual	2023
Revenue:	KRW17.46B
Gross Profit:	KRW9.07B (51.96 %)
EPS:	KRW132.36

FY	2023
Revenue:	KRW17.46B
Gross Profit:	KRW9.07B (51.96 %)
EPS:	KRW132.36

FY	2022
Revenue:	KRW16.25B
Gross Profit:	KRW8.47B (52.13 %)
EPS:	KRW117.19

Financial Reports:

No articles found.

CrystalGenomics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

CrystalGenomics, Inc.

CrystalGenomics, Inc., a biopharmaceutical company, discovers and develops structural chemoproteiomics-based drugs in Korea. Its lead development candidate is NSAID (CG100649), which is a tissue specific anti-inflammatory agent with cardiovascular, gastrointestinal, and renal safety profiles that has completed Phase IIa clinical trial. The company's drug candidates also include CG200745, a histone deacetylase inhibitor for cancer, which is in Phase I clinical trial; and CG400549, an antibiotic candidate for methicillin resistant staphylococcus aureus and vancomycin resistant staphylococcus aureus, which is in Phase I clinical trial. In addition, it offers cloning, expression, purification, and characterization of proteins of interest; and assay and structure services. The company has drug discovery collaborations with AstraZeneca, Daiichi-Sankyo, SBI-Biotech, Carna Biosciences, Yuyu Pharma, AmorePacific, Hanmi Pharmaceuticals, and ProQuest Investments. CrystalGenomics, Inc. was founded in 2000 and is headquartered in Seongnam, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.